First and foremost, remember that diet is individual, even when it comes to your GLP-1 diet
With microdosing, the initial dose may be as low as 0.05 milligrams weekly, with a slower increase in the dose than usual. Full doses can range all the way up to 2.4 milligrams per week, depending on the brand and the specific needs of the person being prescribed the medication
These options are particularly well-suited for patients with mild to moderate skin laxity or those who prefer a gradual approach
Semaglutide (Ozempic/Wegovy) is more effective at reducing blood sugar levels than liraglutide (Saxenda)
See Section 7 for full medication coding guidance
While the share of ESI enrollees with a GLP-1 drug claim has been increasing, still only a relatively modest number of people have a claim Since 2012, the share of non-elderly adults with ESI that have a GLP-1 drug claim has grown more than eightfold (717.7% increase)